This project focuses on developing a biofortified tomato with significantly increased beta-carotene levels through gene editing. By enhancing the lycopene-beta-cyclase (LCYB) enzyme efficiency, the nutritional value of tomatoes is improved, addressing vitamin A deficiency.
This innovative research aims to develop a biofortified tomato variety with increased beta-carotene levels to combat global vitamin A deficiency. The approach involves gene-editing the lycopene-beta-cyclase (LCYB) enzyme, which plays a crucial role in converting lycopene to beta-carotene. By enhancing LCYB's efficiency, the project's goal is to significantly boost beta-carotene content in tomatoes, thereby enhancing their nutritional value and providing a dietary solution to vitamin A deficiency.
Key features:
The current development stage of this biofortified tomato is at Technology Readiness Level 2, indicating that the concept has been formulated and initial experimental research has been conducted. Further validation and refinement of the gene-editing strategy are planned to progress toward higher readiness levels.
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.